Opus Genetics, Inc. (IRD)
4.76
-0.11
(-2.26%)
USD |
NASDAQ |
Sep 25, 16:00
4.765
0.00 (0.00%)
After-Hours: 19:59
Opus Genetics Price : 4.76 for Sept. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | 4.89 | 4.93 | 4.70 | 4.76 | 1.245M |
| Sep 24, 2026 | 4.76 | 4.955 | 4.60 | 4.87 | 1.831M |
| Sep 23, 2026 | 5.14 | 5.155 | 4.645 | 4.83 | 3.056M |
| Sep 22, 2026 | 5.20 | 5.30 | 5.04 | 5.16 | 1.173M |
| Sep 21, 2026 | 5.17 | 5.55 | 5.17 | 5.22 | 1.981M |
| Sep 18, 2026 | 5.29 | 5.339 | 5.11 | 5.18 | 5.543M |
| Sep 17, 2026 | 5.46 | 5.62 | 5.23 | 5.28 | 1.532M |
| Sep 16, 2026 | 5.80 | 5.80 | 5.345 | 5.41 | 2.335M |
| Sep 15, 2026 | 5.94 | 5.95 | 5.671 | 5.82 | 1.993M |
| Sep 14, 2026 | 6.02 | 6.22 | 5.795 | 5.97 | 2.552M |
| Sep 11, 2026 | 6.16 | 6.576 | 5.77 | 6.04 | 4.658M |
| Sep 10, 2026 | 5.87 | 6.24 | 5.40 | 6.07 | 6.537M |
| Sep 09, 2026 | 5.31 | 7.07 | 5.31 | 5.73 | 54.32M |
| Sep 08, 2026 | 4.532 | 4.623 | 4.305 | 4.34 | 2.269M |
| Sep 04, 2026 | 4.53 | 4.80 | 4.40 | 4.67 | 2.240M |
| Sep 03, 2026 | 4.655 | 4.83 | 4.28 | 4.60 | 4.426M |
| Sep 02, 2026 | 3.86 | 4.52 | 3.86 | 4.45 | 4.998M |
| Sep 01, 2026 | 3.65 | 3.85 | 3.59 | 3.83 | 868853.0 |
| Aug 31, 2026 | 3.71 | 3.72 | 3.511 | 3.62 | 584222.0 |
| Aug 28, 2026 | 3.85 | 3.86 | 3.63 | 3.69 | 823647.0 |
| Aug 27, 2026 | 3.80 | 3.92 | 3.79 | 3.85 | 547536.0 |
| Aug 26, 2026 | 4.17 | 4.21 | 3.77 | 3.80 | 908741.0 |
| Aug 25, 2026 | 4.07 | 4.42 | 4.035 | 4.11 | 1.501M |
| Aug 24, 2026 | 4.02 | 4.238 | 3.82 | 4.03 | 812173.0 |
| Aug 21, 2026 | 4.16 | 4.33 | 4.02 | 4.05 | 1.053M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Faeth Therapeutics, Inc. | 28.00 |
| Perspective Therapeutics, Inc. | 2.52 |
| Rezolute, Inc. | 3.90 |
| Praxis Precision Medicines, Inc. | 280.78 |
| Nuvectis Pharma, Inc. | 20.22 |
Price Related Metrics
| PS Ratio | 40.91 |
| Earnings Yield | -28.92% |
| Market Cap | 393.40M |